Silver Book Fact

Parkinson’s disease is the 2nd-most common neurodegenerative disease in the U.S., second only to Alzheimer’s disease.

Nussbaum, Robert L, and Christopher E Ellis. Genomic Medicine: Alzheimer’s Disease and Parkinson’s Disease. N Engl J Med. 2003; 348(14): 1356-64. http://www.nejm.org/doi/full/10.1056/NEJM2003ra020003

Reference

Title
Genomic Medicine: Alzheimer’s Disease and Parkinson’s Disease
Publication
N Engl J Med
Publication Date
2003
Authors
Nussbaum, Robert L, and Christopher E Ellis
Volume & Issue
Volume 348, Issue 14
Pages
1356-64
URL
Read Full Resource

Categories

  • Cost of Disease
  • Prevalence & Incidence

Related Facts

  • The number of Medicare claims for Alzheimer’s disease treatment grew by 250% during the 1990s, and is expected to increase by 300% over the next 10 years.  
  • Average Medicare Costs for Hospital, Nursing Home and Home Health Care for Beneficiaries Age 65+ with Alzheimer’s Disease and Other Dementias Compared with Other Beneficiaries, 2000  
  • Out-of-pocket costs for Medicare beneficiaries age 65 and older with Alzheimer’s disease and other dementias who were living in the community were 1.2 times higher than the average for all…  
  • By the time the symptoms of Parkinson’s disease are apparent, as much as 80% of dopamine-producing cells have been damaged.  
  • In 2012, total out-of-pocket spending for individuals with Alzheimer’s and other dementias is estimated at $33.8 billion